BioFocus Expands Ion Channel Offering Through Agreement with ChanTest

06 Feb 2013
Share
BioFocus and ChanTest today announced an agreement which will enable BioFocus to offer ChanTest’s extensive cell line library (> 200 products) and Channel Panel™ profiling services. This expands BioFocus’ offering in the fields of ion channel, GPCR and transporter targets for drug discovery.

“With access to ChanTest’s cell line collection and ion channel profiling, we have further augmented our suite of integrated drug discovery services, designed to deliver efficiency and success to our partners,” said Kate Hilyard, VP Biological Sciences, BioFocus.

Chris Mathes, Ph.D., M.B.A, Chief Commercial Officer, ChanTest, commented, “This collaboration with BioFocus fits well with ChanTest’s integrated CRO strategy, and we are delighted to partner with a company with such a strong reputation.”

Request Info


Company website

BioFocus